Comparison of a New Intranasal Naloxone Formulation to Intramuscular Naloxone: Results from Hypothesis-generating Small Clinical Studies

Clinical and Translational Science
B T GuffordMary F Paine

Abstract

Easy-to-use naloxone formulations are needed to help address the opioid overdose epidemic. The pharmacokinetics of i.v., i.m., and a new i.n. naloxone formulation (2 mg) were compared in six healthy volunteers. Relative to i.m. naloxone, geometric mean (90% confidence interval [CI]) absolute bioavailability of i.n. naloxone was modestly lower (55%; 90% CI, 43-70% vs. 41%; 90% CI, 27-62%), whereas average (±SE) mean absorption time was substantially shorter (74 ± 8.8 vs. 6.7 ± 4.9 min). The opioid-attenuating effects of i.n. naloxone were compared with i.m. naloxone (2 mg) after administration of oral alfentanil (4 mg) to a separate group of six healthy volunteers pretreated with 240 mL of water or grapefruit juice. The i.m. and i.n. naloxone attenuated miosis by similar extents after water (40 ± 15 vs. 41 ± 21 h*%) and grapefruit juice (49 ± 18 vs. 50 ± 22 h*%) pretreatment. Results merit further testing of this new naloxone formulation.

References

Jan 1, 1990·European Archives of Psychiatry and Clinical Neuroscience·J GrünbergerN Loimer
Jan 16, 2002·Prehospital Emergency Care : Official Journal of the National Association of EMS Physicians and the National Association of State EMS Directors·Erik D BartonWilliam Dunn
Jul 9, 2002·Emergency Medicine Journal : EMJ·A-M Kelly, Z Koutsogiannis
Aug 2, 2003·Clinical Pharmacology and Therapeutics·David J GreenblattMiguel A Zinny
Oct 9, 2003·Clinical Pharmacokinetics·Stanley S Davis, Lisbeth Illum
Jan 18, 2005·The Medical Journal of Australia·Anne-Maree KellyZeff Koutsogiannis
Apr 27, 2005·The Medical Journal of Australia·Ariella GlaserRobert S Hoffman
Feb 1, 2006·Basic & Clinical Pharmacology & Toxicology·Laura Juntti-PatinenPertti J Neuvonen
May 4, 2007·International Journal of Pharmaceutics·Henry R CostantinoSteven C Quay
Jul 22, 2008·Therapeutic Drug Monitoring·Jonathonm DowlingAndis Graudins
Jan 14, 2010·Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Société Canadienne Des Sciences Pharmaceutiques·Anaísa PiresAmílcar Falcão
Mar 13, 2010·The American Journal of Emergency Medicine·Mark A MerlinPeter W Pryor
Feb 18, 2011·Current Problems in Dermatology·Christoph BitterChristian Surber
Apr 7, 2011·JAMA : the Journal of the American Medical Association·Amy S B BohnertFrederic C Blow
Dec 4, 2012·Drug and Alcohol Dependence·Raminta DaniulaityteAmit Sheth
Apr 24, 2013·Therapeutics and Clinical Risk Management·David Alexander Sclar
Jun 5, 2013·Drug Delivery and Translational Research·Daniel P Wermeling
Jun 20, 2013·Phytochemical Analysis : PCA·Karen M VandermolenNicholas H Oberlies
Apr 25, 2014·The New England Journal of Medicine·Nora D VolkowStephen S Cha
May 17, 2014·Prehospital Emergency Care : Official Journal of the National Association of EMS Physicians and the National Association of State EMS Directors·Matthew ZuckermanEdward W Boyer
Jun 7, 2014·Archives of Medical Science : AMS·Ali Mohammad SabzghabaeeSamaneh Zandifar
Jul 31, 2014·Population Health Management·Roxanne MeyerSamir H Mody
Dec 4, 2014·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Amanda Robinson, Daniel P Wermeling
May 4, 2015·BMJ Case Reports·Ryan MacDonaldJared Strote

❮ Previous
Next ❯

Citations

Oct 11, 2017·Pharmaceutical Development and Technology·Lari K DkharAli Seyfoddin
May 17, 2019·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Sarah G MahonskiHong K Kim
Aug 26, 2018·European Journal of Clinical Pharmacology·Ida TylleskarOla Dale
Aug 28, 2018·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·Alex Wang, Aaron S Kesselheim
Mar 29, 2021·Resuscitation·Carsten LottUNKNOWN ERC Special Circumstances Writing Group Collaborators
Jun 16, 2021·Notfall & Rettungsmedizin·Carsten LottJasmeet Soar

❮ Previous
Next ❯

Methods Mentioned

BETA
pregnancy test

Software Mentioned

Phoenix WinNonlin
Phoenix
WinNonlin

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Anesthesia
R SchwagmeierH W Striebel
Prehospital Emergency Care : Official Journal of the National Association of EMS Physicians and the National Association of State EMS Directors
Corey S DavisAlexander Y Walley
European Journal of Clinical Pharmacology
Timo IirolaKlaus T Olkkola
© 2022 Meta ULC. All rights reserved